Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 27, 2002

View Archived Issues

New melanocortin agonists in early development at Lilly

BMS researchers synthesize novel antiamyloidogenic agents

Rigel and Daiichi team up for cancer drug discovery

EluSys receives funding for anthrax Heteropolymer

Alfacell expands Onconase research collaboration with NCI

Restructuring at Insmed to advance most promising drug candidates

DACH-platinum compound compares favorably with currently marketed platinum compounds

Oral and parenteral formulations of Vfend now available for serious fungal infections

Advisory committee review of Fabry's disease products delayed

Vardenafil: phase III clinical data discussed at congress, trade name selected

Update on phase II and III clinical studies of Theratope in breast cancer

Oral ZD-6474 inhibits VEGF-induced angiogenesis and tumor growth in mice

Safety of PS-341 demonstrated in patients with advanced solid tumors

ISIS-3521 and ISIS-5132 evaluated as single agents in HRPC

New data on the tolerability of LY-355703 in patients with refractory solid tumors

Pharmacokinetic data reported for extended-release metformin at recent meeting

Anticancer drug combination safe and effective against malignant pleural mesothelioma

Effect of BIM-44058 on trabecular microarchitecture in monkey model of postmenopausal osteoporosis

Noncalcemic vitamin D analogue inhibits prostate cancer cell growth and PTHrP gene expression

Toa Eiyo presents new agents for diabetes and lipoprotein disorders

LDL receptor upregulators covered by Takeda patent

New inhibitors of cell adhesion prepared and tested at Kowa

Roche describes synthesis, biological activity and potential uses of CDK2 inhibitors

G17DT granted fast track status for pancreatic cancer

Bone loss in inflammatory arthritis prevented by CLX-0921 and etanercept

Marketing approval sought in E.U. for triple combination Parkinson's therapy

Enrollment and treatment completed in phase I/II trial of DTI-015 in brain cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...